Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
The “Ones to Recognise” group represents the best of the companies selected for the Profit Track 100 main category but this year did not meet the category’s financial criteria. However, these companies are viewed to have shown excellent past profits and forecast further rapid financial growth.
Jonathan de Pass, Chairman and Founder of Evaluate, said: “Being named in this category is an endorsement of our staff’s dedication to rapidly and profitably growing the business by making Evaluate’s products essential for the life sciences marketplace. It is an honour to be recognised by BDO and the Sunday Times as a business to watch.”
Evaluate provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors.
Our Evaluate Omnium and Evaluate Pharma® platforms offer unique and dynamic insights into pharma asset risk and commercial potential alongside a seamless, comprehensive view of the pharmaceutical market landscape.
Evaluate Vantage – our award-winning, independent editorial team – provides thought-provoking news and insights into current and future industry developments.
Evaluate has been a partner to industry-leading organisations for 25 years. For more information on how we give our clients the time and understanding to drive better decisions, visit www.evaluate.com.
For media inquiries, please contact email@example.com.